It's not hard to come up with that $15 target.
The current market size is around US$4.5bill and growing.
Given Spontan's clear advantages, it is not difficult to think that it could reach at least a 2-3% market share reasonably quickly. It definitely might be able to do better.
3% of US$4.5bill is US$135mill. This is a very high margin product. Gross profit could exceed 90% or US$121.5mill
That's A$181mill. I'm allowing 15% of that GP ($27mill) is spent on overheads and R&D.
That would leave NPBT of A$154mill and NPAT of A$108mill if paying the full 30% tax rate.
I'd expect strong year on year growth and therefore a potential PE of 20. That would require a market cap of A$2.157bill and a sp of $13.
A 5% market share bumps my sp target to $21.70.
These are unrisked targets. They still need regulatory approval and then to deliver the market share so I'd expect a very volatile ride.
- Forums
- ASX - By Stock
- LTP
- Valuation
LTP
ltr pharma limited
Add to My Watchlist
1.45%
!
34.0¢

Valuation, page-13
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $38.06M |
Open | High | Low | Value | Volume |
35.0¢ | 36.3¢ | 33.0¢ | $174.7K | 507.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11094 | 34.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.0¢ | 5555 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11094 | 0.340 |
1 | 89552 | 0.335 |
3 | 77516 | 0.330 |
1 | 25000 | 0.325 |
3 | 35125 | 0.320 |
Price($) | Vol. | No. |
---|---|---|
0.360 | 5555 | 1 |
0.365 | 11302 | 1 |
0.375 | 40000 | 1 |
0.385 | 33091 | 2 |
0.390 | 25000 | 1 |
Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
Featured News
LTP (ASX) Chart |